access

News

US imposes limits on COVID-19 boosters and new jabs

The FDA has introduced a stricter set of policies around COVID-19 vaccines, including requiring clinical trials for new shots in some cases.

Patients

Biosimilars: Unlocking access, closing the cost divide

Every day, countless Americans are forced to choose between meeting basic needs such as food, housing, or transportation and paying for their medications.

News

Germany will reimburse haemophilia gene therapy Hemgenix

Germany has agreed to reimburse CSL Behring's haemophilia B gene therapy Hemgenix with a 'unique' outcomes-based payment model.

News

First drug backed for NHS use in untreated Hodgkin lymphoma

Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated late-stage Hodgkin lymphoma.

News

Pharma furious as UK Statutory Scheme rebate rate soars

The UK pharma sector has reacted with consternation to the government's proposal to raise the Statutory Scheme rate to 32.2% in the last half of 2025.

R&D